🚀 VC round data is live in beta, check it out!
Fagron Valuation Multiples
Discover revenue and EBITDA valuation multiples for Fagron and similar public comparables like Piramal Pharma, PharmaResearch, Sai Life Sciences, Jiuzhou Pharmaceutical and more.
Fagron Overview
About Fagron
Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies that are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America, and Fagron Latin America. The majority of its revenue comes from Fagron North America.
Founded
1990
HQ
Employees
4.0K
Website
Financials (LTM)
EV
$2B
Fagron Financials
Fagron reported last 12-month revenue of $1B and EBITDA of $239M.
In the same LTM period, Fagron generated $741M in gross profit, $239M in EBITDA, and $118M in net income.
Revenue (LTM)
Fagron P&L
In the most recent fiscal year, Fagron reported revenue of $1B and EBITDA of $229M.
Fagron expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $741M | XXX | $509M | XXX | XXX | XXX |
| Gross Margin | 63% | XXX | 45% | XXX | XXX | XXX |
| EBITDA | $239M | XXX | $229M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| Net Profit | $118M | XXX | $113M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Debt | — | — | $268M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Fagron Stock Performance
Fagron has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Fagron's stock price is $28.75.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 4.3% | XXX | XXX | XXX | $1.54 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFagron Valuation Multiples
Fagron trades at 2.1x EV/Revenue multiple, and 10.2x EV/EBITDA.
EV / Revenue (LTM)
Fagron Financial Valuation Multiples
As of April 19, 2026, Fagron has market cap of $2B and EV of $2B.
Equity research analysts estimate Fagron's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Fagron has a P/E ratio of 17.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | 10.2x | XXX | 10.7x | XXX | XXX | XXX |
| EV/EBIT | 13.4x | XXX | 14.1x | XXX | XXX | XXX |
| EV/Gross Profit | 3.3x | XXX | 4.8x | XXX | XXX | XXX |
| P/E | 17.9x | XXX | 18.7x | XXX | XXX | XXX |
| EV/FCF | 26.7x | XXX | 16.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Fagron Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Fagron Margins & Growth Rates
Fagron's revenue in the last 12 month grew by 13%.
Fagron's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Fagron's rule of 40 is 37% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Fagron's rule of X is 61% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Fagron Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | 15% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 37% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 61% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 30% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Fagron Public Comps
See public comps and valuation multiples for other Contract Research & Manufacturing comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Fagron | XXX | XXX | XXX | XXX | XXX | XXX |
| Piramal Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| PharmaResearch | XXX | XXX | XXX | XXX | XXX | XXX |
| Sai Life Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Jiuzhou Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| ST Pharm | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Fagron M&A Activity
Fagron acquired XXX companies to date.
Last acquisition by Fagron was on XXXXXXXX, XXXXX. Fagron acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Fagron
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialFagron Investment Activity
Fagron invested in XXX companies to date.
Fagron made its latest investment on XXXXXXXX, XXXXX. Fagron invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Fagron
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Fagron
| When was Fagron founded? | Fagron was founded in 1990. |
| Where is Fagron headquartered? | Fagron is headquartered in Belgium. |
| How many employees does Fagron have? | As of today, Fagron has over 4K employees. |
| Who is the CEO of Fagron? | Fagron's CEO is Rafael Padilla. |
| Is Fagron publicly listed? | Yes, Fagron is a public company listed on Euronext Brussels. |
| What is the stock symbol of Fagron? | Fagron trades under FAGR ticker. |
| When did Fagron go public? | Fagron went public in 2007. |
| Who are competitors of Fagron? | Fagron main competitors are Piramal Pharma, PharmaResearch, Sai Life Sciences, Jiuzhou Pharmaceutical. |
| What is the current market cap of Fagron? | Fagron's current market cap is $2B. |
| What is the current revenue of Fagron? | Fagron's last 12 months revenue is $1B. |
| What is the current revenue growth of Fagron? | Fagron revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Fagron? | Current revenue multiple of Fagron is 2.1x. |
| Is Fagron profitable? | Yes, Fagron is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Fagron? | Fagron's last 12 months EBITDA is $239M. |
| What is Fagron's EBITDA margin? | Fagron's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Fagron? | Current EBITDA multiple of Fagron is 10.2x. |
| What is the current FCF of Fagron? | Fagron's last 12 months FCF is $91M. |
| What is Fagron's FCF margin? | Fagron's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of Fagron? | Current FCF multiple of Fagron is 26.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.